Sign In
Buy RXST
$4.79
-0.150 (-3.04%)
At Close: Jun 03, 2026
RxSight, Inc. (RXST) Q1 2023 Earnings Call Transcript
07:14pm, Saturday, 13'th May 2023
RxSight, Inc. (NASDAQ:RXST ) Q1 2023 Results Conference Call May 9, 2023 4:30 PM ET Company Participants Alex Huang - Director, IR Ron Kurtz - President and CEO Shelley Thunen - CFO Conference Call Pa
RxSight, Inc. (RXST) Reports Q1 Loss, Tops Revenue Estimates
07:52pm, Tuesday, 09'th May 2023
RxSight, Inc. (RXST) came out with a quarterly loss of $0.42 per share versus the Zacks Consensus Estimate of a loss of $0.52. This compares to loss of $0.54 per share a year ago.
RxSight, Inc. to Present at the Bank of America Healthcare Conference
04:05pm, Wednesday, 26'th Apr 2023
ALISO VIEJO, Calif., April 26, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients followi
RxSight, Inc. to Report First Quarter Financial Results on May 9, 2023
04:05pm, Tuesday, 25'th Apr 2023
ALISO VIEJO, Calif., April 25, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients followi
Here's Why RxSight, Inc. (RXST) is a Great Momentum Stock to Buy
01:02pm, Tuesday, 11'th Apr 2023
Does RxSight, Inc. (RXST) have what it takes to be a top stock pick for momentum investors? Let's find out.
RxSight, Inc. to Present at the Needham Healthcare Conference
04:05pm, Wednesday, 05'th Apr 2023
ALISO VIEJO, Calif., April 05, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients follow
4 Best Breakout Stocks to Buy Now for Superlative Returns
09:13am, Wednesday, 29'th Mar 2023
CymaBay Therapeutics (CBAY), RxSight (RXST), UWM (UWMC) & Remitly Global (RELY) have been selected as the breakout stocks for today.
How Much Upside is Left in RxSight, Inc. (RXST)? Wall Street Analysts Think 25.69%
11:29am, Monday, 13'th Mar 2023
The consensus price target hints at a 25.7% upside potential for RxSight, Inc. (RXST). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings est
RxSight, Inc. (RXST) Q4 2022 Earnings Call Transcript
08:19pm, Monday, 06'th Mar 2023
RxSight, Inc. (NASDAQ:RXST ) Q4 2022 Earnings Conference Call March 6, 2023 4:30 PM ET Company Participants Alex Huang – Investor Relations Ron Kurtz – President and Chief Executive Officer Shelle
RxSight, Inc. to Present at the Oppenheimer Healthcare Conference
04:05pm, Tuesday, 28'th Feb 2023
ALISO VIEJO, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high quality customized vision to patients following cataract surgery,
RxSight, Inc. to Report Fourth Quarter and Fiscal Year 2022 Financial Results on March 6, 2023
04:05pm, Tuesday, 21'st Feb 2023
ALISO VIEJO, Calif., Feb. 21, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high quality customized vision to patients followin
RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference
04:05pm, Wednesday, 28'th Dec 2022
ALISO VIEJO, Calif., Dec. 28, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, toda
Is RxSight (RXST) Stock Outpacing Its Medical Peers This Year?
11:17am, Tuesday, 06'th Dec 2022
Here is how RxSight, Inc. (RXST) and Lantheus Holdings (LNTH) have performed compared to their sector so far this year.
RxSight, Inc. (RXST) Q3 2022 Earnings Call Transcript
06:28pm, Monday, 07'th Nov 2022
RxSight, Inc. (NASDAQ:RXST ) Q3 2022 Results Conference Call November 7, 2022 4:30 PM ET Company Participants Alex Huang - Associate Director of Investor Relations Ron Kurtz - President and Chief Exec
RxSight, Inc. to Report Third Quarter 2022 Financial Results on November 7, 2022
04:05pm, Monday, 24'th Oct 2022
ALISO VIEJO, Calif., Oct. 24, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, toda
